Overexpressed SIRT6 ameliorates doxorubicin-induced cardiotoxicity and potentiates the therapeutic efficacy through metabolic remodeling

MLA

Kezheng Peng, et al. “Overexpressed SIRT6 Ameliorates Doxorubicin-Induced Cardiotoxicity and Potentiates the Therapeutic Efficacy through Metabolic Remodeling.” Acta Pharmaceutica Sinica B, vol. 13, no. 6, June 2023, pp. 2680–700. EBSCOhost, https://doi.org/10.1016/j.apsb.2023.03.019.

APA

Kezheng Peng, Chenye Zeng, Yuqi Gao, Binliang Liu, Liyuan Li, Kang Xu, Yuemiao Yin, Ying Qiu, Mingkui Zhang, Fei Ma, & Zhao Wang. (2023). Overexpressed SIRT6 ameliorates doxorubicin-induced cardiotoxicity and potentiates the therapeutic efficacy through metabolic remodeling. Acta Pharmaceutica Sinica B, 13(6), 2680–2700. https://doi.org/10.1016/j.apsb.2023.03.019

Chicago

Kezheng Peng, Chenye Zeng, Yuqi Gao, Binliang Liu, Liyuan Li, Kang Xu, Yuemiao Yin, et al. 2023. “Overexpressed SIRT6 Ameliorates Doxorubicin-Induced Cardiotoxicity and Potentiates the Therapeutic Efficacy through Metabolic Remodeling.” Acta Pharmaceutica Sinica B 13 (6): 2680–2700. doi:10.1016/j.apsb.2023.03.019.